Skip to Main Content

Author Details

Beth Wilmot
Knight Cancer Institute, Oregon Health & Science University
2004
64
25
PMIDPaper TitleJournal TitlePublished Year
36264026Secondary fusion proteins as a mechanism of BCR::ABL1 kinase-independent resistance in chronic myeloid leukaemia.Br J Haematol2023
36848718The Oregon ADHD-1000: A new longitudinal data resource enriched for clinical cases and multiple levels of analysis.Dev Cogn Neurosci2023
34482403Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML.Blood2022
35499387Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Operative in Acute Myeloid Leukemia.Mol Cancer Ther2022
35868306Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.Cancer Cell2022
36307214Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia.Cold Spring Harb Mol Case Stud2022
35279027Optimizing Translational Research for Exceptional Health and Life Span: A Systematic Narrative of Studies to Identify Translatable Therapeutic Target(s) for Exceptional Health Span in Humans.J Gerontol A Biol Sci Med Sci2022
31973781Smaller total brain volume but not subcortical structure volume related to common genetic risk for ADHD.Psychol Med2021
33888254NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease Classification: JACC State-of-the-Art Review.J Am Coll Cardiol2021
34233449Aurora A kinase as a target for therapy in <i>TCF3-HLF</i> rearranged acute lymphoblastic leukemia.Haematologica2021
31605387Evaluating chronic emotional dysregulation and irritability in relation to ADHD and depression genetic risk in children with ADHD.J Child Psychol Psychiatry2020
32033925Polygenic Risk Score-Derived Subcortical Connectivity Mediates Attention-Deficit/Hyperactivity Disorder Diagnosis.Biol Psychiatry Cogn Neurosci Neuroimaging2020
32066674Large epigenome-wide association study of childhood ADHD identifies peripheral DNA methylation associated with disease and polygenic risk burden.Transl Psychiatry2020
33123685Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia.Nat Cancer2020
30651561Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms.Nat Commun2019
31667711Polymorphisms in oxidative stress pathway genes and prostate cancer risk.Cancer Causes Control2019
31779979What do functional genomics tell us about pathogenesis of AML?Best Pract Res Clin Haematol2019
31366621Genomic landscape of neutrophilic leukemias of ambiguous diagnosis.Blood2019
29786871Gender-Specific Effects of Selection for Drinking in the Dark on the Network Roles of Coding and Noncoding RNAs.Alcohol Clin Exp Res2018
30018082Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemia.Sci Signal2018
29930110Analysis of shared heritability in common disorders of the brain.Science2018
30333627Functional genomic landscape of acute myeloid leukaemia.Nature2018
29496126Working Memory and Vigilance as Multivariate Endophenotypes Related to Common Genetic Risk for Attention-Deficit/Hyperactivity Disorder.J Am Acad Child Adolesc Psychiatry2018
28630439Recurrent cyclin D2 mutations in myeloid neoplasms.Leukemia2017
28439110Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations.Leukemia2017
28360221<i>NFAT5</i> and <i>SLC4A10</i> Loci Associate with Plasma Osmolality.J Am Soc Nephrol2017
28332277Sequencing of sporadic Attention-Deficit Hyperactivity Disorder (ADHD) identifies novel and potentially pathogenic de novo variants and excludes overlap with genes associated with autism spectrum disorder.Am J Med Genet B Neuropsychiatr Genet2017
28652245Unpaired Extracellular Cysteine Mutations of CSF3R Mediate Gain or Loss of Function.Cancer Res2017
27004716Pathway analysis in attention deficit hyperactivity disorder: An ensemble approach.Am J Med Genet B Neuropsychiatr Genet2016
26304033Methylomic analysis of salivary DNA in childhood ADHD identifies altered DNA methylation in VIPR2.J Child Psychol Psychiatry2016
26677978Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis.Cancer Res2016
26708334HitWalker2: visual analytics for precision medicine and beyond.Bioinformatics2016
25043339Limited clinical utility of a genetic risk score for the prediction of fracture risk in elderly subjects.J Bone Miner Res2015
26625308Src and STAT3 inhibitors synergize to promote tumor inhibition in renal cell carcinoma.Oncotarget2015
26367794Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture.Nature2015
26177520Predisposition to Childhood Otitis Media and Genetic Polymorphisms within the Toll-Like Receptor 4 (TLR4) Locus.PLoS One2015
26032424Therapeutically Targetable ALK Mutations in Leukemia.Cancer Res2015
26059482Gene set analysis: A step-by-step guide.Am J Med Genet B Neuropsychiatr Genet2015
25924931plethy: management of whole body plethysmography data in R.BMC Bioinformatics2015
25652416Splicing landscape of the eight collaborative cross founder strains.BMC Genomics2015
23929584Genetic susceptibility to chronic otitis media with effusion: candidate gene single nucleotide polymorphisms.Laryngoscope2014
25459302â¿¿Pitfalls in the application of gene set analysis to genetics studiesâ¿¿: a response.Trends Genet2014
25154796Functional and genomic context in pathway analysis of GWAS data.Trends Genet2014
25172470Analysis considerations for utilizing RNA-Seq to characterize the brain transcriptome.Int Rev Neurobiol2014
24374554The genetics of gene expression in complex mouse crosses as a tool to study the molecular underpinnings of behavior traits.Mamm Genome2014
23096700Copy number variation analysis in 98 individuals with PHACE syndrome.J Invest Dermatol2013
28824928PHENOTYPIC VARIABILITY IN INDIVIDUALS WITH TYPE V OSTEOGENESIS IMPERFECTA WITH IDENTICAL IFITM5 MUTATIONS.J Rare Disord2013
24286512Comparison of methods to identify aberrant expression patterns in individual patients: augmenting our toolkit for precision medicine.Genome Med2013
23656643Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.N Engl J Med2013
23704919Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.PLoS One2013
  • 1 - 50 of 64

Recommended Authors

Vanderbilt University Medical Center
Career Start Year 2009
Number of shared co-authors 49
Ontario Institute for Cancer Research
Career Start Year 2009
Number of shared co-authors 42
Fred Hutchinson Cancer Research Center
Career Start Year 2007
Number of shared co-authors 19
Duke University
Career Start Year 2007
Number of shared co-authors 20
Cleveland Institute for Computational Biology, Case Western Reserve University
Career Start Year 2006
Number of shared co-authors 40
Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai
Career Start Year 2006
Number of shared co-authors 11
University of British Columbia and BC Children's Hospital
Career Start Year 2006
Number of shared co-authors 37
Kidney Research Institute and Division of Nephrology, University of Washington
Career Start Year 2006
Number of shared co-authors 12
Vanderbilt University Medical Center
Career Start Year 2006
Number of shared co-authors 156
Scripps Science Institute
Career Start Year 2005
Number of shared co-authors 22
University of Southern California
Career Start Year 2004
Number of shared co-authors 74
Graduate School of Medicine, The University of Tokyo
Career Start Year 2004
Number of shared co-authors 25
University of California San Diego Health System
Career Start Year 2004
Number of shared co-authors 116
Boston Children's Hospital, Seoul National University, Seoul National University Hospital
Career Start Year 2003
Number of shared co-authors 5
Biomedical and Translational Informatics Institute
Career Start Year 2003
Number of shared co-authors 78
Department of Pediatrics and Rady's Children's Hospital, University of California
Career Start Year 2002
Number of shared co-authors 150
University of Washington
Career Start Year 2002
Number of shared co-authors 8
University of California los angeles
Career Start Year 2001
Number of shared co-authors 2
Boston University School of Public Health
Career Start Year 2001
Number of shared co-authors 160
Broad Institute of MIT and Harvard
Career Start Year 2001
Number of shared co-authors 110
Keck School of Medicine, University of Southern California
Career Start Year 2001
Number of shared co-authors 1
University of Pennsylvania
Career Start Year 2001
Number of shared co-authors 48
Center for Systems Genomics, Pennsylvania State University, University Park
Career Start Year 2001
Number of shared co-authors 101
NIHR Maudsley Biomedical Research Centre, King's College London
Career Start Year 2000
Number of shared co-authors 58
Icahn School of Medicine at Mount Sinai
Career Start Year 1998
Number of shared co-authors 148
William Harvey Research Institute, Queen Mary University of London
Career Start Year 1997
Number of shared co-authors 128
university of california los angeles
Career Start Year 1993
Number of shared co-authors 65
Center for Applied Genomics (CAG), Children's Hospital of Philadelphia
Career Start Year 1987
Number of shared co-authors 62
University of California San Diego
Career Start Year 1987
Number of shared co-authors 176
University of California, USA Institute for Genomic Medicine
Career Start Year 1967
Number of shared co-authors 19

Collaborators

Oregon Health & Science University, University of California Berkeley
Co-authored papers 40
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 25
Oregon Health & Science University School of Medicine
Co-authored papers 20
Oregon Health & Science University
Co-authored papers 16
Knight Cancer Institute Oregon Health & Science University Portland Oregon USA.
Co-authored papers 13
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 13
Oregon Health & Science University
Co-authored papers 11
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 9
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 8
Portland Alcohol Research Center, Oregon Health and Science University
Co-authored papers 7
Knight Cancer Institute Oregon Health & Science University Portland Oregon USA.
Co-authored papers 7
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 7
Oregon Health and Science University
Co-authored papers 7
Oregon Health & Science University
Co-authored papers 7
Oregon Health & Science University, Knight Cancer Institute
Co-authored papers 7
University of Utah Huntsman Cancer Institute
Co-authored papers 6
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 6
SUNY Upstate Medical University
Co-authored papers 6
University of Texas Southwestern Medical Center
Co-authored papers 6
Oregon Health & Science University
Co-authored papers 5
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 5
University of Minnesota Medical School
Co-authored papers 5
University of Colorado Division of Hematology
Co-authored papers 5
Oregon Health and Science University
Co-authored papers 4
Metabolism and Clinical Nutrition, Oregon Health and Sciences University.
Co-authored papers 4
Clinical Research Division, Fred Hutchinson Cancer Center
Co-authored papers 4
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
National Cancer Institute, National Institutes of Health
Co-authored papers 4